Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: J Immunol. 2013 Mar 1;190(7):3732–3739. doi: 10.4049/jimmunol.1202964

Table 2. Summary of affinity and neutralizing activity for Fab 19 or related Fab mutants possessing reverted unmutated ancestor residues.

Location of
reversion to
unmutated
ancestor
Antibody Steady-state
affinity (KD)
(M)
Neutralizing specific activity
(μg/mL needed to
neutralize)
None wt Fab 19 2.9 × 10−8 3
CDR1 T134F 1.8 × 10−8 1
L136F 5.0 × 10−8 4
G138S 1.5 × 10−7 13
T140S 7.2 x 10−7 120
CDR2 T159S 5.2 x 10−8 3
G160S 7.0 × 10−8 4
G161S 3.3 × 10−8 2
N163S 1.2 × 10−7 3
F164Y 1.6 × 10−6 130
CDR3 T205R 1.3 × 10−7 9
P210A 1.7 × 10−6 >200
P211H 1.6 × 10−6 >200
H215Y 2.8 × 10−6 >200